The genetic makeup and structure of glioblastoma tumors can shift dramatically across different regions of a single tumor, according to a Northwestern Medicine study published in Science Advances.

Glial fibrillary acidic protein (GFAP) is a potential biomarker for early, preclinical changes in patients with transthyretin amyloid polyneuropathy (ATTR-PN) and could aid in early detection, ...

A new study by Mass General Brigham researchers provides a glimmer of hope for patients with glioblastoma, the most common and deadly form of brain cancer in adults. Skip to content.

Summary: The phase 2B SURVIVE trial testing SurVaxM, a cancer vaccine for glioblastoma, will continue as planned following an interim analysis showing sufficient promise to proceed.SurVaxM, combined ...

Among patients with recurrent glioblastoma (GBM), the combination of VXM01, an investigational oral anti–VEGFR-2 vaccine, and the PD-L1 inhibitor avelumab (Bavencio) was generally well tolerated, with ...

Background: Glioblastoma is the most prevalent and aggressive primary malignant brain tumor, known for its rapid growth and local invasion. While it predominantly remains within the central nervous ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis – the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients ...

Glioblastoma (GBM) is one of the most lethal central nervous systems (CNS) tumours in adults. As supplements to standard of care (SOC), various immunotherapies improve the therapeutic effect in other ...

Glioblastoma, also known as glioblastoma multiforme (GBM) or a grade 4 astrocytoma, is one of the most common and aggressive brain cancers, causing about 50% of all gliomas. Although it is a ...

Immunofluorescence images showing GFAP, Ki-67, and CD133 in the peri-tumoral region of glioblastoma patients. B. The proportion of GFAP+ and/or CD133+ in Ki-67+ cells in glioblastoma patients.

Glioblastoma is a rare but aggressive type of cancer that can develop in your brain or spinal cord. Learn about symptoms, causes, treatment, and outlook.

The study presented here investigated human GBM tissues using a multiplex panel comprised of GFAP, TMEM119, CD68, c-Maf and CD163, the HISTOPROFILE ® Neuro M1/M2.